Kintor Pharmaceutical’s COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment
Kintor Pharmaceutical Limited is delighted to announced that the clinical trial of anti-androgen treatment Proxalutamide...
Global Coalition for Adaptive Research, Amgen, and Eisai Announce First Patient Enrolled in International...
The Global Coalition for Adaptive Research (GCAR) in collaboration with Amgen and Eisai Co., Ltd.,...
AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ in Atopic...
AbbVie at the 29th European Academy of Dermatology and Venereology (EADV) Virtual Congress show that...
Baxter Supports New Study Showing Blood Purification with Oxiris Filter Set Can Play a...
Baxter International Inc., a global leader in acute care, recognizes the findings of a prospective,...
LabCorp Transforms the Clinical Trial Experience And Streamlines the Druag Development Process
LabCorp , a leading global life sciences company that is focused on advancing health and...
GSK presents positive clinical data on maternal and older adults RSV candidate vaccines
GSK announced that its Respiratory Syncytial Virus (RSV) candidate vaccines for maternal immunisation (GSK3888550A) and...
Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials
AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in...
Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical...
At Johnson & Johnson, there is no greater priority than the safety and well being...
Kodiak begins three phase 3 studies of anti-VEGF antibody biopolymer conjugate, KSI-301 to treat...
Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to...
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating...
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the...
